Active ingredientMolsidomineCat. No. P-M161-001CAS 25717-80-0Family · Pharmaceutical analytical standards
Molsidomine
An orally active vasodilator, first synthesised in Japan in 1970, used to prevent angina pectoris and for its long-term treatment. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It is a prodrug: the liver turns it into linsidomine (SIN-1), an unstable molecule that releases nitric oxide as it breaks down, and nitric oxide is what actually widens the blood vessels.
Go to the active ingredient →Active ingredientMolsidomineCat. No. P-M161-001CAS 25717-80-0
Pharmacopoeial impurityMolsidomine EP Impurity A HydrochlorideCat. No. P-M161-002CAS 16142-27-1
ImpurityMorpholineCat. No. P-M161-003CAS 110-91-8
Pharmacopoeial impurityMolsidomine EP Impurity CCat. No. P-M161-004CAS 26179-71-5
Pharmacopoeial impurityMolsidomine EP Impurity DCat. No. P-M161-005CAS 4394-85-8
Isotopically labelledMolsidomine-d5Cat. No. P-M161-007
NitrosamineMolsidomine EP Impurity BCat. No. P-M161-008CAS 59-89-2
Impurity1,3-Oxazolidin-2,4-dioneCat. No. P-M161-009CAS 2346-26-1
Impurity2-(Morpholinoamino)acetonitrileCat. No. P-M161-010CAS 16142-26-0
Impurity4-(Hydroxyacetyl)morpholineCat. No. P-M161-011CAS 51068-78-1No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceMolsidomine CRSEDQM code Y0000821Family MolsidomineImpurityMolsidomine impurity B CRSEDQM code Y0000822Family MolsidomineImpurityMolsidomine impurity D CRSEDQM code Y0000823Family MolsidomineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.